Synthpop raises $15M Series A
Synthpop, a healthcare AI firm focused on automating administrative workflows across payers, providers and patients, raised $15 million in a Series A round. The company positions its product on administrative automation rather than clinical AI, according to reporting on the funding (Healthcare AI Company Synthpop Raises $15 Million to Automate Administrative Workflows).
Synthpop said on February 3 it raised a $15 million Series A to build more artificial intelligence tools for healthcare paperwork, not diagnosis. (synthpop.ai) The Cambridge, Massachusetts, company said the round was led by Ansa Capital and brings total funding to $23 million. Defy.vc, Peterson Ventures, Storm Ventures and investor Bruce Broussard also participated, and Ansa co-founder Marco DeMeireles joined the board. (businesswire.com) Synthpop says its software combines document reading, insurer-specific rules and voice agents to handle tasks such as prior authorization, claims and patient intake across payers, providers and patients. The company said the platform can automate up to 80% of healthcare business processes. (finance.yahoo.com) Those jobs sit in the part of healthcare that patients usually experience as forms, phone calls and delays before treatment starts. UnitedHealthcare and Humana both direct providers to online systems for eligibility checks, referrals, prior authorizations, claims and appeals, showing how much administrative work sits between a doctor visit and payment. (uhcprovider.com) (provider.humana.com) Federal health programs use prior authorization and pre-claim review to check whether services meet Medicare rules before or around the time care is delivered. That review process is one reason startups are targeting back-office automation instead of clinical decision-making. (cms.gov) Synthpop has framed that bet consistently since its earlier financings. In a 2024 seed announcement, the company cited a McKinsey estimate that simplifying and standardizing healthcare administration could save up to $265 billion a year. (synthpop.ai) The founders are Chief Executive Officer Elad Ferber and Jan Jannink, according to the company and Crunchbase. Synthpop says Ferber previously co-founded remote patient monitoring company Spry Health, which was acquired by Itamar Medical in 2021. (synthpop.ai) (crunchbase.com) (synthpop.ai) The company has also been adding engineering talent as it tries to turn that pitch into deployed software. In a March 2026 post, Synthpop said the Airt team had joined the company to work on agentic workflow automation. (synthpop.ai) For now, the new money is aimed at the least glamorous part of healthcare technology: the billing, authorization and intake work that keeps patients waiting and staff on the phone. Synthpop is betting investors will fund software that cuts those steps down before they fund more tools that try to practice medicine. (sleepreviewmag.com)
